China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'ALA-PDT combined with immunotherapy for locally advanced and metastatic cSCC'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600133080
Registration Time: 2026/09/21
Type: Interventional study
Primary Sponsor: Shanghai Skin Disease Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343845
Published by HT Digital Content Services with permission from Health Daily Digest....